Welcome and Introduction
Christine Waszynski
Vision and Journey of Age Friendly Health Systems 2016-present
Alice Bonner
Terry Fulmer
PhD, RN, FAAN
The 4 M's: What Matters
Alice Bonner
The 4 M's: Mobility
The 4 M's: Medication
John Devlin
The 4 M's: Mentation (depression, dementia, delirium)
Sharon Inouye
BREAK
Promoting Health Equity With the 4M's
Documenting the 4Ms in the Electronic Health Record
Exemplar Program Acute Care
Min Ji Kwak
MD, MS, DrPH
Exemplar Program Across the Care Continuum
Spreading the 4 M’s to the Community
Mary Dolansky
MD
Lunch Panel
Donna Fick
Alice Bonner
Terry Fulmer
PhD, RN, FAAN
Clay Angel
MD
The 4 Ms in Delirium Prevention and Intervention: Mobility. This session is 40min long, it will repeat four times during the block.
This session is 40min long, it will repeat four times during the block
1:00 – 1:40 PM
1:45 – 2:25 PM
2:30- 3:10 PM
3:15- 3:55 PM
Nimit Agarwal
MD
Nicholas Reed
Michelle Nai
Alasdair MacLullich
Noll Campbell
Donna Fick
The 4 Ms in Delirium Prevention and Intervention: Medications. This session is 40min long, it will repeat four times during the block
This session is 40min long, it will repeat four times during the block
1:00 – 1:40 PM
1:45 – 2:25 PM
2:30- 3:10 PM
3:15- 3:55 PM
The 4 Ms in Delirium Prevention and Intervention: Mentation (Delirium, Dementia/Depression). This session is 40min long, it will repeat four times during the block
This session is 40min long, it will repeat four times during the block
1:00 – 1:40 PM
1:45 – 2:25 PM
2:30- 3:10 PM
3:15- 3:55 PM
The 4 Ms in Delirium Prevention and Intervention: What Matters? This session is 40min long, it will repeat four times during the block
This session is 40min long, it will repeat four times during the block
1:00 – 1:40 PM
1:45 – 2:25 PM
2:30- 3:10 PM
3:15- 3:55 PM
Delirium Escape Room Demo and Debrief
Karri Davis
Arlene Stoller
Michelle Nai
Jeanne Kessler
Kerri Maya
Christine Waszynski
Closing Remarks
Esther Oh
MD, PhD
Exhibit Hours
Registration and Breakfast
Research Mentor-Mentee Breakfast
Welcome: Presidential Address and Meeting Announcements
Christine Waszynski
Esther Oh
MD, PhD
Clay Angel
MD
Plenary: Age Friendly Health Systems
Terry Fulmer
PhD, RN, FAAN
Plenary: Mouse Icu Environment Model Of Delirium
Nadia Lunardi
BREAK
Delirium In Emergency Depts Implementing Best Practices
Anna Satake
Jin Han
Katren Tyler
Funding Opportunities For Delirium Research
Babar Khan
Yewande Akinbami
Susan Zieman
Luci Roberts
Oral Abstracts: Session 1
A Delirium Risk Stratification Tool & Delirium Rounds To Prevent Delirium In Hospitalized Older Adults
Jennifer Woodword
Tru Byrnes
Alice Bonner
Advancement Of EEG Technologies And Approaches For Better Clinical Practice
Lisbeth Anne Evered
Sudhin Shah
Gen Shinozake
Eyal Kimchi
Arjen Slooter
Oral Abstracts: Session 2
Statistical Consultation Roundtable For Junior Investigators
Elizabeth Caolantuoni
Michael Harhay
Rich Jones
LUNCH
Exhibitor Forum - EyeControl
Addressing Delirium In The Acute And Post-Acute Care Setting
Rebecca Spear
Carmen Goudeau
NIDUS Symposium
• NIDUS II Delirium Research Network: Overview and What NIDUS II Can Do for You – Sharon K. Inouye, MD, MPH
• NIDUS II Measurement Core: Harmonization of Delirium Measures –Richard N. Jones, ScD
• NIDUS II Animal Models Working Group-- Niccolo Terrando, PhD for the DREAM Group
• Discussant—Luci Roberts, PhD
Niccolo Terrando
Rich Jones
Luci Roberts
Sharon Inouye
From Mouse Models and Mechanisms to Therapeutic Targets for Delirium
This symposium presents new advances in clinically-relevant mouse models for delirium and the intersecting mechanisms of aging, metabolism, and neuroinflammation that help shed light on biological mechanisms of delirium.
This preclinical science symposium moderated by Dr. Newman will present new advances in clinically-relevant preclinical models for delirum, mechanisms of metabolism and neurovascular function in neurodegeneration relevant to delirium, and peri-surgical neuroinflammatory mechanisms relevant to delirium.
Dr. Lahiri will describe insights into the specific inflammatory mediators of delirum-like phenotypes from novel, clinically-relevant mouse models of ventilator-associated lung injury and urinary tract infection.
Dr. Lin will present her recent work using basic and translational science approaches to study of aging-related metabolic mechanisms, including TOR inhibition and nutritional interventions, affect delirium-relevant neurovascular and neurometabolic function in mouse models of aging and Alzheimer’s disease.
Dr. Yang will present new data from mouse model of post-operative cognitive impairment of the mechanisms of neuroinflammation and mediators of inflammatory resolution that will inform new therapeutic targets for delirium.
Objectives of this symposium are to advance the audience’s undertsanding of
1) clinically-relevant preclinical models for delirum
2) mechanisms of metabolism and neurovascular function in neurodegeneration relevant to delirium
3) peri-surgical neuroinflammatory mechanisms relevant to delirium
John Newman
MD PhD
Ting Yang
MD PhD
Ai-Ling Lin
PhD
Shouri Lahiri
The Evolution Of Care For ICU Delirium In Critically Ill Infants And Children
Leslie Dervan
John Lin
John Berkenbosch
Heidi Smith
Cognitive Sparing Strategies: Insights from Animal Models
Laura Zhang
Ravi Velagapudi
Beverly Orser
Submitting Delirium Research To Journals
Karin Neufeld
Daniel Davis
Ben Lee
Jim Rudolph
Nidus Oral Abstracts 1
Moderators: Edward Marcantonio, MD, SM and John Devlin, PharmD
2:40-2:55: Pre- and postoperative CSF proteomic signatures of postoperative delirium. Michael Devinney
2:55-3:10: Association of gut microbiome and delirium in acutely ill older adults. Flavia Garcez
3:10-3:25: A feasibility study of a non-pharmacological delirium prevention intervention for hospitalised MÄori and non-MÄori with advanced cancer. Annmarie Hosie
3:25-3:40: Characterization of ICU delirium among liver transplant recipients. Jessica Ruck
Delirium in Palliative Care
Denise Kresevic
Meera Agar
Ann Marie Hosie
Shirley Bush
Michelle Weckman
Parsing Delirium Beyond Motoric Subtypes
Alasdair MacLullich
Karin Neufeld
Mark Oldham
Arjen Slooter
The New Frontier For Delirium Prevention & Management: Translation And Implementation Of Evidence Into Hospital And Rehab At Home Models
Gideon Caplan
Heidi Lindroth
Karly Mucks
Erin Shadbolt
Margaret Paulson
Oral Abstracts: Session 3
Delirium In The Critically Ill Patient
Lisa Burry
Eduardo Tobar
Federico Carini
Poster Viewing and Reception
Social event
401 E Michigan St,
Indianapolis, IN 46204
(Transportation is not provided)
Exhibit Hours
Registration And Continental Breakfast
Research Committee
Educational Committee
Membership Committee
Pediatrics Special Interest Group (SIG)
Latin American Delirium Special Interest Group (LADIG)
Awards & Announcements
Plenary: Perioperative Delirium
Lisbeth Anne Evered
Plenary: Innovation and Implementation - A C-Suite Perspective
Arif Nazir
BREAK
Implementation Strategies for Long-term Success using Integrated Education in the Electronic Medical Record
Kathryn Agarwal
Meg Sands
Alasdair MacLullich
Karin Neufeld
Novel Approaches To Understanding Delirium Pathophysiology: From Preclinical Models To Clinical Samples
Gideon Caplan
Esther Oh
MD, PhD
Sarinnapha Vasunilashorn
Niccolo Terrando
Gen Shinozake
Nidus Pilot Award Research Presentation
Moderators: John Devlin, PharmD and Pratik Pandharipande, MD, MSc
10:20-10:40: Potentiation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPAR) by highly-sulfated chondroitin sulfate: a novel contributor to sepsis- associated delirium. Joseph Hippensteel
10:40-11:00: Computable phenotyping of delirium: analyzing the unstructured data. Kimberly Oosterhouse
11:05-11:20: Validating the fluctuating mental status evaluation: a novel delirium screening tool for critically ill patients with stroke. Ravikrah Velagpudi
Oral Abstracts: Session 4
Delirium & Covid-19 Connecting Pathophysiology Through Biomarkers Of Inflammation
Esther Oh
MD, PhD
Sophia Wang
Sikandar Khan
Chani Traube
Relationship Between Delirium And Disrupted Sleep And Circadian Rhythms
Kendall Smith
Lei Gao
Benjamin Palanca
Mark Oldham
Addressing Delirium in the Perioperative Period
Michael Devinney
Susana Vacas
Christina Boncyk
David Scott
Nidus Oral Abstracts 2
Moderators: Jan Busby Whitehead, MD, MPH and Richard Jones, ScD
11:45-12:00: Pre-ICU anxiety and depression and risk of delirium in critically ill adults. Ting Ting Wu
12:00-12:15: Expression of behavioral and psychological symptoms of dementia with and without concomitant delirium. Shih Yin Lin
12:15-12:30: Fog ahead: delirium and post-discharge cognitive impairment in Severe COVID-19. Thiago Avelino-Silva
12:30-12:45: A scoping review of perceptions from healthcare professionals on antipsychotic prescribing practices in acute care settings. Natalia Jaworksa
LUNCH
The Business Case For Delirium
Victor Tabbush
Jose Azar
Expanding Delirium From The Binary To The Spectrum: The Importance Of Distress And Measuring Delirium Recovery
Zoe Tieges
Heidi Lindroth
Composite Endpoints In Delirium Research Studies
Catherine Auriemma
Elizabeth Caolantuoni
Michael Harhay
Implementation Of A Delirium Screening And Prevention Program In Surgical Patients
Jasmine Demos
Andzelika Dechnik
Frederick Sieber
Dianne Bettick
Susan Gearhart
Educational Strategies For Healthcare Professionals Surrounding Delirium: Process And Outcomes
Karri Davis
Arlene Stoller
Thiago Avelino-Silva
Michelle Nai
Jeanne Kessler
Kerri Maya
Christine Waszynski
Novel Designs For Delirium Trials
Kert Viele
Elizabeth Caolantuoni
Michael Harhay
Open Business Meeting